<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9607835</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20545</journal-id>
<journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Molecular psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1359-4184</issn>
<issn pub-type="epub">1476-5578</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28948973</article-id>
<article-id pub-id-type="pmc">6459194</article-id>
<article-id pub-id-type="doi">10.1038/mp.2017.191</article-id>
<article-id pub-id-type="manuscript">NIHMS976744</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Gestational diabetes exacerbates maternal immune activation effects in the developing brain</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Money</surname>
<given-names>Kelli M.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barke</surname>
<given-names>Theresa L.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Serezani</surname>
<given-names>Ana</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gannon</surname>
<given-names>Maureen</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garbett</surname>
<given-names>Krassimira A.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aronoff</surname>
<given-names>David M.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mirnics</surname>
<given-names>Karoly</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="author-notes" rid="FN1">#</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Neuroscience Graduate Program, Vanderbilt University, Nashville, TN 37232, USA</aff>
<aff id="A2">
<label>2</label>Vanderbilt Medical Scientist Training Program, Vanderbilt University, Nashville, TN 37232, USA</aff>
<aff id="A3">
<label>3</label>Graduate Program in Microbiology and Immunology, Vanderbilt University, Nashville, TN 37232, USA</aff>
<aff id="A4">
<label>4</label>Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA</aff>
<aff id="A5">
<label>5</label>Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN 37232, USA</aff>
<aff id="A6">
<label>6</label>Division of Allergy, Pulmonary and Critical Care, Vanderbilt University Medical Center, Nashville, TN 37232, USA</aff>
<aff id="A7">
<label>7</label>Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, TN 37232, USA</aff>
<aff id="A8">
<label>8</label>Department of Medicine, and Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA</aff>
<aff id="A9">
<label>9</label>Munroe-Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, NE 68198, USA</aff>
<author-notes>
<corresp id="FN1">Correspondence: Karoly Mirnics, MD, PhD, Director, Munroe-Meyer Institute for Genetics and Rehabilitation, Hattie B. Munroe Professor, University of Nebraska Medical Center, 985450 Nebraska Medical Center â€“ MMI Rm 2005, Omaha, NE 68198-5450, (402) 559-6430, <email>karoly.mirnics@unmc.edu</email></corresp>
<fn fn-type="equal" id="FN2">
<label>*</label>
<p>These authors contributed equally to this manuscript</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>23</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>11</day>
<month>4</month>
<year>2019</year>
</pub-date>
<volume>23</volume>
<issue>9</issue>
<fpage>1</fpage>
<lpage>9</lpage>
<!--elocation-id from pubmed: 10.1038/mp.2017.191-->
<abstract>
<p id="P1">Maternal inflammation and diabetes increase the risk for psychiatric disorders in offspring. We hypothesized that these co-occurring risk factors with may potentiate each other. To test this, we maternally exposed developing mice <italic>in utero</italic> to gestational diabetes mellitus (GDM) and/or maternal immune activation (MIA). Fetal mouse brains were exposed to either vehicle, GDM, MIA, or GDM+MIA. At gestational day (GD) 12.5, GDM produced a hyperglycemic, hyperleptinemic maternal state whereas MIA produced significant increases in pro-inflammatory cytokines and chemokines. Each condition alone resulted in an altered, inflammatory and neurodevelopmental transcriptome profile. In addition, GDM+ MIA heightened the maternal inflammatory state and gave rise to a new, specific transcriptional response. This exacerbated response was associated with pathways implicated in psychiatric disorders, including dopamine neuron differentiation and innate immune response. Based on these data, we hypothesize that children born to GDM mothers and exposed to mid-gestation infections have an increased vulnerability to psychiatric disorder later in life, and this should be tested in follow-up epidemiological studies.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>